Replies to post #364071 on Innovation Pharmaceuticals Inc (IPIX)

[KMBJN]

Ralph Baric and colleagues at UNC did CoV and flu gain of function research (with Wuhan batwoman Shi), and were involved in the development of molnupavir/EIDD-2801/Ridgeback/Merck's oral Covid drug:

https://www.unc.edu/posts/2020/04/06/carolina-researchers-key-role-in-the-development-of-new-covid-19-treatment/

https://www.technologyreview.com/2021/06/29/1027290/gain-of-function-risky-bat-virus-engineering-links-america-to-wuhan/

https://mindmatters.ai/2021/06/u-s-moratoriumish-on-gain-of-function-research/

Politics of molnupavir:

https://www.sciencemag.org/news/2020/05/emails-offer-look-whistleblower-charges-cronyism-behind-potential-covid-19-drug

I still wonder about the behind-the-scenes action resulting in Dr. Bright stepping down from BARDA. Sounds fishy.

https://abcnews.go.com/Politics/head-vaccine-development-alleges-cronyism-removed-post/story?id=70286813

We'll see the efficacy-safety profile of molnupavir compared to brilacidin. Molnupavir has big sponsors and ease of administration, but likely much more toxicity.

[Longpicker]

Concerning gain of function research, more info is coming out: